Amylin-type fusion protein and its coding gene and use

  title={Amylin-type fusion protein and its coding gene and use},
The invention discloses a recombinant amylin-type fusion protein for diabetes treatment and is coding gene and use. The invention provides the amylin-type fusion protein, its coding gene and a method for highly expressing the amylin-type fusion protein. The amylin-type fusion protein is a protein obtained by partial or complete fusion of N terminal amino acid residue of amylin-type peptide and carboxyl terminal (C terminal) amino acid residue sequence of an artificial short peptide. The amylin… CONTINUE READING

Similar Papers